Company Profiles

driven by the PitchBook Platform

AlveoliX

PRIVATE STATUS
Seed LATEST DEAL TYPE
$20.8k LATEST DEAL AMOUNT
$20.8k TOTAL AMOUNT RAISED
1 INVESTORS
Description

Developer of an in-vitro lung model for drug testing. The company helps in mimicking the biophysical characterstics of the lung. It also predicts the effects of respiratory drug candidates in humans and thus reduces the number of candidates to be tested in clinical trials.

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Primary Office
Murtenstrasse 50
3010 Bern
Switzerland
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore AlveoliX’s full profile, request a free trial.

AlveoliX Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Seed Round $20.8k $20.8k Completed Startup
To view this company’s complete deal history including valuation and funding request access »

AlveoliX Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Venture kick Accelerator/Incubator Minority 000 0000 000000 0

You’re viewing 1 of 1 investors.

AlveoliX Executive Team (1)

Name Title Board
Seat
Contact
Info
Olivier Guenat Founder

You’re viewing 1 of 1 executives.